Amway India bullish, targets revenues of Rs 6,000 crore by 2025

Amway has also invested Rs 600 crore in a manufacturing facility in Madurai, as part of the Rs 1000 crore investment plan in India. 

“We have registered a CAGR of 20 per cent over the last 20 years which is testimony to the robustness of our business model and importance of the Indian market, which ranks among the top markets for us. 

We are eyeing a three-fold growth in our business by 2025, fuelled by innovations and digital penetration along with our strong direct sellers network and focus on engaging young consumers,” Amway India CEO Anshu Budhraja said. Globally, US-based Amway is over 59 years old, with a turnover of $ 8.6 billion. 

Amway plans to invest around Rs 100 crore over the next 2-3 years in India, which includes Rs 70 crore investment in R&D, Rs 10 crore in manufacturing and Rs 20-30 crore in digital initiatives.  

As part of its customer outreach and engagement plan, a significant portion of the investment is committed to launching Amway XPP stores in India. The company will be adding 25 more Xpress Pick and Pay (XPP) stores across India during 2018. 

As per market estimates, the direct selling FMCG industry is pegged at Rs 65,000 cr by 2025, clocking an almost six-fold growth from its current size. 

It also aims to double the revenue of nutrition and wellness, the biggest revenue driver, by 2025. It noted with the increasing demand for the vitamins and dietary supplements, which has a current market size of Rs 8,400 crore, is poised to grow at 10 per cent in the next five years.